"It Can't Hurt!": Why Many Patients With Limited Life Expectancy Decide to Accept Lung Cancer Screen...
"It Can't Hurt!": Why Many Patients With Limited Life Expectancy Decide to Accept Lung Cancer Screening
About this item
Full title
Author / Creator
Publisher
United States: Annals of Family Medicine
Journal title
Language
English
Formats
Publication information
Publisher
United States: Annals of Family Medicine
Subjects
More information
Scope and Contents
Contents
Lung cancer screening (LCS) has less benefit and greater potential for iatrogenic harm among people with multiple comorbidities and limited life expectancy. Yet, such individuals are more likely to undergo screening than healthier LCS-eligible people. We sought to understand how patients with marginal LCS benefit conceptualize their health and make...
Alternative Titles
Full title
"It Can't Hurt!": Why Many Patients With Limited Life Expectancy Decide to Accept Lung Cancer Screening
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11237214
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11237214
Other Identifiers
ISSN
1544-1709,1544-1717
E-ISSN
1544-1717
DOI
10.1370/afm.3081
